Bartlett & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Bartlett & Co’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,825	Closed	-$72K	–	1066
2021 Q1	$72K	Hold	5,825	–	–	﹤0.01%	478
2020 Q4	$83K	Hold	5,825	–	–	﹤0.01%	449
2020 Q3	$81K	Hold	5,825	–	–	﹤0.01%	410
2020 Q2	$62K	Hold	5,825	–	–	﹤0.01%	457
2020 Q1	$47K	Buy	+5,825	New	+$48.6K	﹤0.01%	477

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bartlett & Co's RDY Position: Q2 2021 in Review

Bartlett & Co sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 5,825 shares — an estimated $72K sold.

Bartlett & Co first reported a position in RDY in Q1 2020 and held it in 5 quarters. The position peaked at $83K in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

Bartlett & Co reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
Bartlett & Co sold 5,825 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $72K.
Bartlett & Co first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 5 quarters.
Bartlett & Co's Dr. Reddy's Laboratories position peaked at $83K in Q4 2020.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Bartlett & Co's 13F filing for Q2 2021, filed 19 Jul 2021.